Robots Theme in Financial Markets
Swing Trader for Beginners: Trading in Markets Trending Down (TA&FA) Annualized Return + 61%
and
Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA) Annualized Return + 48%
Theme Robots -- 1 week change +2.91%
$CGNX $IRBT $ISRG $ROK $ZBRA
Theme Description
Robots encompass companies that venture into the creation of robotic technology that serves diverse functions, from lawn maintenance to complex medical procedures for cardiovascular diseases. The rise of automation and robotics is a landmark achievement in contemporary technology. Such advancements have sparked debates regarding its potential impact on the human labor market. A few firms in this sector include Stereotaxis Inc., known for its cardiology instrument navigation systems; Edwards Lifesciences Corp., which offers solutions for late-stage cardiovascular diseases; and iRobot Corp., which produces robots for household chores like mopping.
Key Companies within the Robot Theme
Market Capitalization Insights
The average market capitalization across the robot-themed companies stands at 31.5B. The valuation range for these firms varies widely, with ISRG taking the lead with a hefty valuation of 100.4B and IRBT being on the lower side, valued at 1.1 B.
Price Fluctuations and Noteworthy News
The robot theme observed an average weekly price increase of 2.91%. However, this trend hasn't been uniform throughout, with IRBT recording the highest price jump at 5.79%, and on the flip side, ZBRA registering a decrease of -1.32%.
Other significant news includes:
Volume Analysis
For the theme, the average weekly volume growth was noted at -21.24%. In terms of a longer duration, the monthly and quarterly volume growth averaged at -8.19% and 6.29%, respectively.
Fundamental Analysis Metrics
For a clearer understanding of the robot theme's financial health and potential, a look into their fundamental analysis ratings is essential. The ratings, where a score of 1 is the best and 100 the worst, are:
This analysis provides a holistic view of the robotic theme in the financial market, shedding light on their performance, potential, and position in the broader industry landscape.
The Aroon Indicator for CGNX entered a downward trend on February 20, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 179 similar instances where the Aroon Indicator formed such a pattern. In of the 179 cases the stock moved lower. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on February 13, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CGNX as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CGNX turned negative on February 04, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .
CGNX moved below its 50-day moving average on February 13, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CGNX crossed bearishly below the 50-day moving average on February 14, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CGNX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CGNX advanced for three days, in of 306 cases, the price rose further within the following month. The odds of a continued upward trend are .
CGNX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.766) is normal, around the industry mean (6.337). P/E Ratio (64.231) is within average values for comparable stocks, (64.639). CGNX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.167). Dividend Yield (0.007) settles around the average of (0.022) among similar stocks. P/S Ratio (8.643) is also within normal values, averaging (30.152).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CGNX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CGNX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of robotic technologies used for surgeries
Industry MedicalSpecialties